Identification of fetal nucleated red blood cells in the maternal circulation during pregnancy using anti-hemoglobin-ε antibody

被引:15
作者
Mavrou, A
Kolialexi, A
Antsaklis, A
Korantzis, A
Metaxotou, C
机构
[1] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Obstet & Gynecol 1, GR-11527 Athens, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, GR-26110 Patras, Greece
关键词
noninvasive prenatal diagnosis; anti-epsilon antibody; fetal NRBCs; fetal hemoglobins;
D O I
10.1159/000071971
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To investigate the use of anti-hemoglobin-epsilon, antibody in order to identify fetal cells in the maternal circulation during pregnancy. Materials and Methods: 48 blood samples were obtained from pregnant women, 26 in the 1st trimester and 22 in the 2nd trimester. Magnetic activated cell sorting was used for fetal cell enrichment followed by immunophenotyping with a monoclonal antibody against hemoglobin-epsilon. FISH with X, Y and 21 chromosome-specific probes was performed in 29 cases. Results: The mean number of epsilon-positive cells was 9.2 (range 2-23) in the 1st trimester, 4.8 (range 3-13) in the 2nd trimester and 22 (range 15-28) in pregnancies with Down syndrome. No significant difference was noted in the number of c-positive nucleated red blood cells (NRBCs) isolated from carriers and noncarriers of beta-thalassemia. FISH analysis was successful in 24 cases. In 4 cases with known male fetuses, an average of 4.7 epsilon-positive cells showed a Y signal. In 4 cases with Down syndrome, all F-positive cells showed 3 signals for chromosome 21. Conclusion: Anti-hemoglobin-epsilon, antibody has increased specificity for fetal NRBCs and should be preferentially used to improve noninvasive prenatal diagnosis of chromosome abnormalities from fetal cells in maternal blood. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 25 条
[1]  
Al-Mufti R, 2000, HAEMATOLOGICA, V85, P690
[2]  
Al-Mufti R, 2001, HAEMATOLOGICA, V86, P1270
[3]  
ALBITAR M, 1989, BLOOD, V74, P629
[4]   PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies [J].
Bianchi, DW ;
Williams, JM ;
Sullivan, LM ;
Hanson, FW ;
Klinger, KW ;
Shuber, AP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) :822-829
[5]   Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood [J].
Cheung, MC ;
Goldberg, JD ;
Kan, YW .
NATURE GENETICS, 1996, 14 (03) :264-268
[6]   Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization [J].
Choolani, M ;
O'Donnell, H ;
Campagnoli, C ;
Kumar, S ;
Roberts, I ;
Bennett, PR ;
Fisk, NM .
BLOOD, 2001, 98 (03) :554-557
[7]  
Farina A, 1998, PRENATAL DIAG, V18, P983, DOI 10.1002/(SICI)1097-0223(199809)18:9<983::AID-PD379>3.3.CO
[8]  
2-M
[9]   Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis:: Experiences with triple density gradient and MACS based on more than 600 cases [J].
Gänshirt, D ;
Smeets, FWM ;
Dohr, A ;
Walde, C ;
Steen, I ;
Lapucci, C ;
Falcinelli, C ;
Sant, R ;
Velasco, M ;
Garritsen, HSP ;
Holzgreve, W .
FETAL DIAGNOSIS AND THERAPY, 1998, 13 (05) :276-286
[10]  
Hogh AM, 2001, CLIN CHEM, V47, P645